Table 6.

Nonadjusted survival models

		HR	95% CI	p-value
CLAD	AA11	1.6	1.1–2.3	0.02
	AA160	1.5	1.0–2.1	0.047
		HR	95% CI	p
DEATH	AA11	1.4	0.89–2.1	0.16
	AA160	0.9	0.5–1.4	0.5

Adjusted Survival Models stratified for donor ethnicity
		HR	95% CI	p-value
CLAD	AA11	1.7	1.1–2.6	0.01
	AA160	1.402	0.9–2.1	0.11
	Age at Transplant	0.955	0.97–1.0	0.68
	Disease: ILD	Ref	Ref	Ref
	Disease: CF	0.643	0.3–1.6	0.33
	Disease: COPD	1.342	0.8–2.3	0.29
	Disease: Other	1.543	0.7–3.4	0.28
	Bilateral Lung-Tx	0.759	0.4–1.3	0.33
	CMV	1.240	0.7–2.1	0.41
		HR	95% CI	p-value
Death	AA11	1.4	0.9–2.2	0.14
	AA160	0.8	0.5–1.4	0.43
	Age at Transplant	1	0.97–1.0	0.94
	Disease: ILD	Ref	Ref	Ref
	Disease: CF	0.4	0.1–1.3	0.12
	Disease: COPD	0.8	0.4–1.6	0.53
	Disease: Other	1.0	0.5–2.4	0.92
	Bilateral Lung-Tx	1.4	0.7–2.9	0.31
	CMV	1.5	0.9–2.7	0.16